High Risk Stocks To Buy 2017 -

: A high-beta tech play that gained 109% due to a surge in demand and pricing for memory chips used in mobile devices and servers. Sector-Specific Risk Profiles

: The maker of Invisalign benefited from a near-monopoly on invisible braces, seeing a 131% increase as it expanded its training to thousands of dentists globally. high risk stocks to buy 2017

: This biotechnology firm was a standout, posting a 426% return in 2017. Its growth was driven by positive clinical trial results for its cholesterol-reducing drug candidate. : A high-beta tech play that gained 109%

For investors in 2017, the "high-risk, high-reward" segment of the market was defined by a strong rebound in energy, explosive breakthroughs in biotechnology, and the rising dominance of high-growth technology. While the broader market saw a lack of volatility, with the S&P 500 rising roughly 20% and the Nasdaq nearly 30%, these specific sectors offered triple-digit gains for those willing to stomach higher volatility. Its growth was driven by positive clinical trial

The following stocks represented some of the most successful speculative plays for the year: